No photo of AMM Eggermont

AMM Eggermont

prof., prof.

    20162025

    Research activity per year

    Personal profile

    Biography

    lid raad van bestuurPrinses Maxima Centrum voor Kinderoncologie1-10-2019
    adviseurCCCMünchen1-1-2022
    adviseurDeutsche Krebshilfe1-9-2019
    adviseurDKFZ-Heidelberg1-1-2020
    Editor-in-chiefEur J Cancer1-1-2020
    chairman boardFondation Cancer, B1-1-2015
    member DSMB Melanoma Trials NKI-AvL1-1-2018
    board memberSAB Ludwig Cancer Inst Lausanne1-1-2022
    board memberEORTC Foundation Board1-1-2011
    IDMCimmuno memberIKR/AvL1-1-2021
    Advisory boardAgenus1-1-2021
    Advisory board/DSMBBiocad1-1-2020
    Advisory boardBioInvent1-1-2020
    IDMCBioNTech1-1-2020
    Advisory boardCatalYm1-1-2022
    Advisory boardClover1-1-2017
    Advisory boardEllipses1-9-2021
    Advisory boardGalecto1-1-2019
    Advisory board/IDMCGSK1-1-2020
    Advisory boardIO Biotech1-2-2022
    Advisory boardMerck1-1-2019
    IDMCPfizer1-6-2019
    Advisory boardSairopa1-6-2021
    Advisory boardSellas1-1-2018
    Advisory boardSkylineDx1-1-2020
    Advisory boardTigaTx1-7-2021
    Advisory boardTTxDiscovery1-10-2021
    Lezingen MelanomaBiocad, BMS, MSD1-1-2021

    External positions

    Lid SAB - Adviseren - Institut Jules Bordet

    1 Jun 2024 → 31 Dec 3999

    Lid SAB - Adviseren - EuroBio

    1 Jun 2024 → 31 Dec 3999

    Member Board - Adviseren - Trained Immunity Discovery

    1 Jan 2024 → 31 Dec 3999

    Lid IDMC - Adviseren - IQVIA

    1 Jan 2023 → 31 Dec 3999

    Lid IDMC - Adviseren - Pfizer

    1 Jan 2022 → 31 Dec 3999

    Lid SAB - Adviseren - IO Biotech

    1 Jan 2022 → 31 Dec 3999

    CMO - CMO - SAIROPA BV

    1 Jan 2022 → 31 Dec 3999

    Lid IDMC - Adviseren - Boehringel Ingelheim

    1 Jan 2022 → 31 Dec 3999

    Lid IDMC (independent data monitoring committee) - Adviseren - BioNTech

    1 Jan 2022 → 31 Dec 3999

    Voorzitter Steering Committee en Voorzitter Vorstand - Besturen en adviseren - Comprehensive Cancer Center Munich

    1 Jan 2022 → 31 Dec 3999

    Lid SAB - Adviseren - CatalYm

    1 Jan 2021 → 31 Dec 3999

    Lid SAB (Scientific adboard) - Lid SAB - BIOINVENT

    1 Jan 2020 → 31 Dec 3999

    Adviseur Trials - Adviseur Trials - Merck & Co and MSD Europe/NL

    1 Jan 2020 → 31 Dec 3999

    Voorzitter - Charity bestuur voorzitten/adviseren - FOCA (FOndation CAncer)

    1 Jan 2019 → 31 Dec 3999

    CMO - Adviseren - Skyline DX BV

    1 Jan 2019 → 31 Dec 3999

    Coordinator Comprehensive Cancer Center Program - Audits - Deutsche Krebshilfe

    1 Jan 2019 → 31 Dec 3999

    Lid Raad van Toezicht - Adviseren - EORTC

    1 Jan 2018 → 31 Dec 3999

    President 2014-2019 / Member Steering Cie 2019-2024 - Adviseren, Policy making - European Academy Cancer Sciences (EACS)

    1 Jan 2014 → 31 Dec 3999

    Collaborations and top research areas from the last five years

    Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
    Explore network further
    • 31 Article
    • 8 Review article
    • 5 Comment/Letter to the editor
    • 1 Meeting Abstract

    • Adjuvant Pembrolizumab in Stage II Melanoma: Outcomes by Primary Tumor Location in the Randomized, Double-Blind, Phase III KEYNOTE-716 Trial

      Yoon, C. H., Ross, M. I., Gastman, B. R., Luke, J. J., Ascierto, P. A., Long, G. V., Rutkowski, P., Khattak, M., Del Vecchio, M., de la Cruz Merino, L., Mackiewicz, J., Chiarion-Sileni, V., Schadendorf, D., Carlino, M. S., Zhao, Y., Fukunaga-Kalabis, M., Krepler, C., Eggermont, A. M., Gershenwald, J. E. & Sondak, V. K., Apr 2025, In: Annals of surgical oncology. 32, 4, p. 2756-2764 9 p.

      Research output: Contribution to journal › Article › Academic › peer-review

      Open Access
      File
      1 Downloads (Pure)

    • Approaches to overcome the current treatment plateau in immunotherapy

      Di Giacomo, A. M., Canetta, R., Connolly, J., Leidner, R., Zheng, W., Kim, Y., Ibrahim, R., Lahn, M., Smith, M., Eggermont, A., Fox, B. A. & Maio, M., 26 Aug 2025, In: European Journal of Cancer. 226, 7 p., 115605.

      Research output: Contribution to journal › Review article › peer-review

      Open Access
      File

    • Correction to: Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours (Nature, (2025), 637, 8048, (1218-1227), 10.1038/s41586-024-08305-z)

      Melero, I., de Miguel Luken, M., de Velasco, G., Garralda, E., Martín-Liberal, J., Joerger, M., Alonso, G., Goebeler, M. E., Schuler, M., König, D., Dummer, R., Reig, M., Rodriguez Ruiz, M. E., Calvo, E., Esteban-Villarrubia, J., Oberoi, A., Sabat, P., Soto-Castillo, J. J., Koster, K. L. & Saavedra, O. & 56 others, Sayehli, C., Gromke, T., Läubli, H., Ramelyte, E., Fortuny, M., Landa-Magdalena, A., Moreno, I., Torres-Jiménez, J., Hernando-Calvo, A., Hess, D., Racca, F., Richly, H., Schmitt, A. M., Eggenschwiler, C., Sanduzzi-Zamparelli, M., Vilalta-Lacarra, A., Trojan, J., Koch, C., Galle, P. R., Foerster, F., Trajanoski, Z., Hackl, H., Gogolla, F., Koll, F. J., Wild, P., Chun, F. K. H., Reis, H., Lloyd, P., Machacek, M., Gajewski, T. F., Fridman, W. H., Eggermont, A. M. M., Bargou, R., Schöniger, S., Rüschoff, J., Tereshchenko, A., Zink, C., da Silva, A., Lichtenegger, F. S., Akdemir, J., Rüdiger, M., L’Huillier, P., Dutta, A., Haake, M., Auckenthaler, A., Gjorgjioska, A., Rössler, B., Hermann, F., Liebig, M., Reichhardt, D., Schuberth-Wagner, C., Wischhusen, J., Fettes, P., Auer, M., Klar, K. & Leo, E., 2025, In: Nature. 639, 8054, p. E18

      Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

      Open Access
      File

    • European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics - Update 2024

      Garbe, C., Amaral, T., Peris, K., Hauschild, A., Arenberger, P., Basset-Seguin, N., Bastholt, L., Bataille, V., Brochez, L., del Marmol, V., Dréno, B., Eggermont, A. M. M., Fargnoli, M. C., Forsea, A. M., Höller, C., Kaufmann, R., Kelleners-Smeets, N., Lallas, A., Lebbé, C. & Leiter, U. & 14 others, Longo, C., Malvehy, J., Moreno-Ramirez, D., Nathan, P., Pellacani, G., Saiag, P., Stockfleth, E., Stratigos, A. J., Van Akkooi, A. C. J., Vieira, R., Zalaudek, I., Lorigan, P., Mandala, M. & On behalf of the European Association of Dermato-Oncology (EADO), the European Dermatology Forum (EDF), and the European Organization for Research and Treatment of Cancer (EORTC), 17 Jan 2025, In: European Journal of Cancer. 215, 115152.

      Research output: Contribution to journal › Article › Academic › peer-review

      Open Access
      File
      1 Downloads (Pure)

    • European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment – Update 2024

      Garbe, C., Amaral, T., Peris, K., Hauschild, A., Arenberger, P., Basset-Seguin, N., Bastholt, L., Bataille, V., Brochez, L., del Marmol, V., Dréno, B., Eggermont, A. M. M., Fargnoli, M. C., Forsea, A. M., Höller, C., Kaufmann, R., Kelleners-Smeets, N., Lallas, A., Lebbé, C. & Leiter, U. & 14 others, Longo, C., Malvehy, J., Moreno-Ramirez, D., Nathan, P., Pellacani, G., Saiag, P., Stockfleth, E., Stratigos, A. J., Van Akkooi, A. C. J., Vieira, R., Zalaudek, I., Lorigan, P., Mandala, M. & On behalf of the European Association of Dermato-Oncology (EADO), the European Dermatology Forum (EDF), and the European Organization for Research and Treatment of Cancer (EORTC), 17 Jan 2025, In: European Journal of Cancer. 215, 115153.

      Research output: Contribution to journal › Article › Academic › peer-review

      Open Access
      File
    View all 45 research outputs